✦ LIBER ✦

Efficacy of lamivudine combined with adefovir dipivoxil versus entecavir monotherapy in patients with hepatitis B-associated decompensated cirrhosis: A meta-analysis

✍ Scribed by Peng, Hong; Liu, Junying; Yang, Min; Tong, Shiwen; Yin, Wenwei; Tang, Hui; Hu, Peng; Hu, Huaidong; Ren, Hong

Book ID: 121292197
Publisher: Sage Publications
Year: 2013
Tongue: English
Weight: 297 KB
Volume: 54
Category: Article
ISSN: 0091-2700
DOI: 10.1002/jcph.181

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of the efficacies of lamivudi

Comparison of the efficacies of lamivudine versus entecavir in patients with hepatitis B virus-related decompensated cirrhosis

✍ Jong Jin Hyun; Yeon Seok Seo; Eileen Yoon; Tae Hyung Kim; Dong Jin Kim; Hyun Seo 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 298 KB

Efficacy and safety of telbivudine plus

Efficacy and safety of telbivudine plus adefovir dipivoxil combination therapy and entecavir monotherapy for HBeAg-positive chronic hepatitis B patients with resistance to adefovir dipivoxil

✍ Lu, Jia-Jie; Liu, Kai; Ma, Yuan-Ji; Wang, Juan; Chen, En-Qiang; Tang, Hong 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB

Efficacy of adefovir add-on lamivudine r

Efficacy of adefovir add-on lamivudine rescue therapy compared with switching to entecavir monotherapy in patients with lamivudine-resistant chronic hepatitis B

✍ Han Jak Ryu; Jung Min Lee; Sang Hoon Ahn; Do Young Kim; Myoung Ha Lee; Kwang-Hyu 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB 👁 1 views

## Abstract No study has reported on the comparative effect of adefovir (ADV) add‐on lamivudine (LAM) versus switching to entecavir (ETV) in LAM‐resistant patients with chronic hepatitis B. From October 2007 to September 2008, 92 consecutive LAM‐resistant patients were enrolled (47 LAM + ADV and 45

The Efficacy of Adefovir Plus Entecavir

The Efficacy of Adefovir Plus Entecavir Combination Therapy in Patients with Chronic Hepatitis B Refractory to Both Lamivudine and Adefovir

✍ Cho, Yuri; Lee, Dong Hyeon; Chung, Kwang Hyun; Jin, Eunhyo; Lee, Jeong-Hoon; Cho 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 264 KB

Efficacy and safety of entecavir versus

Efficacy and safety of entecavir versus adefovir in chronic hepatitis B patients with hepatic decompensation: A randomized, open-label study

✍ Yun-Fan Liaw; Maria Raptopoulou-Gigi; Hugo Cheinquer; Shiv Kumar Sarin; Tawesak 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 436 KB 👁 2 views

A randomized, open-label comparative study of entecavir versus adefovir therapy was performed in subjects with chronic hepatitis B who had hepatic decompensation (Child-Turcotte-Pugh score ≥7). Adult subjects were randomized and treated (n = 191) with entecavir 1.0 mg or adefovir 10 mg daily for up

Mutations associated with the therapeuti

Mutations associated with the therapeutic efficacy of adefovir dipivoxil added to lamivudine in patients resistant to lamivudine with type B chronic hepatitis

✍ Kazuyoshi Ohkawa; Tetsuo Takehara; Michio Kato; Aimi Kanada; Matsuo Deguchi; Mas 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 269 KB

## Abstract Factors influencing the therapeutic efficacy of adefovir dipivoxil added to continuing lamivudine have not been elucidated in lamivudine‐resistant patients with type B chronic hepatitis. The viral mutations influencing the efficacy of treatment with adefovir dipivoxil were investigated